MVCAX | TRMCX | MVCAX / TRMCX | |
Total Expense Ratio | 0.99 | 0.84 | 118% |
Annual Report Gross Expense Ratio | 1.00 | 0.84 | 119% |
Fund Existence | 24 years | 29 years | - |
Gain YTD | 3.814 | 1.535 | 248% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 17.3B | 15.5B | 112% |
Annual Yield % from dividends | 0.87 | 1.30 | 67% |
Returns for 1 year | -1.70 | -5.86 | 29% |
Returns for 3 years | 16.54 | 7.49 | 221% |
Returns for 5 years | 54.59 | 30.66 | 178% |
Returns for 10 years | 67.90 | 21.03 | 323% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
QVAL | 44.62 | 0.22 | +0.50% |
Alpha Architect US Quantitative Val ETF | |||
THRO | 36.34 | 0.16 | +0.44% |
iShares U.S. Thematic Rotation ActiveETF | |||
ULTY | 6.27 | 0.01 | +0.16% |
YieldMax Ultra Option Income Strat ETF | |||
KURE | 19.03 | -0.08 | -0.42% |
KraneShares MSCI All China Hlth Care ETF | |||
BBC | 22.23 | -0.21 | -0.91% |
Virtus LifeSci Biotech Clinical Trls ETF |